Basic Information
LncRNA/CircRNA Name | SOX21-AS1 |
Synonyms | NA |
Region | GRCh38_13:94712716-94716246 |
Ensemble | ENSG00000227640 |
Refseq | NR_046514 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | lung adenocarcinoma |
ICD-0-3 | C34 |
Methods | qPCR, Western blot etc. |
Sample | non-small cell lung cancer tissues, NSCLC adenocarcinoma cell lines (A549, SPC-A1, NCI-H1299, NCI-H1650, PC9, and H1975), NSCLC squamous carcinomas cell lines (H1703, SK-MES-1 and H226) |
Expression Pattern | up-regulated |
Function Description | Higher expression levels of SOX21-AS1 positively correlated with tumor size and advanced tumor-node-metastasis (TNM) stage. Multivariate analyses indicated that SOX21-AS1 expression could serve as an independent prognostic factor for overall survival of LUAD. |
Pubmed ID | 28873379 |
Year | 2017 |
Title | A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation |
External Links
Links for SOX21-AS1 | GenBank HGNC NONCODE |
Links for lung adenocarcinoma | OMIM COSMIC |